Grace Therapeutics (GRCE) Prepaid Assets (2019 - 2026)
Grace Therapeutics' (GRCE) quarterly Prepaid Assets came in at $557000.0 in Q2 2026, up 11.4% year-over-year from $500000.0 in Q2 2025, and up 45.43% quarter-over-quarter from $383000.0 in Q1 2026.
Analysis
Grace Therapeutics (GRCE) Prepaid Assets (2019 - 2026) Analysis & Trends
Grace Therapeutics has disclosed Prepaid Assets across 8 years of filings, most recently posting $557000.0 for Q2 2026.
- In Q2 2026, Prepaid Assets rose 11.4% year-over-year to $557000.0; the TTM figure through Jun 2026 stood at $557000.0 (up 11.4% YoY), while the FY2026 annual figure was $383000.0, down 15.45% from the prior year.
- Prepaid Assets came in at $557000.0 for Q2 2026 at Grace Therapeutics, up from $383000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.5 million in Q2 2022 to a low of $283000.0 in Q1 2024.
- Average Prepaid Assets over 5 years is $723777.8, with a median of $590500.0 recorded in 2023.
- Year-over-year, Prepaid Assets soared 109.91% in 2022 and slumped 54.31% in 2024.
- Over 5 years, Prepaid Assets stood at $1.0 million in 2022, then dropped by 22.17% to $811000.0 in 2023, then declined by 28.11% to $583000.0 in 2024, then slipped by 10.98% to $519000.0 in 2025, then gained by 7.32% to $557000.0 in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $557000.0 in Q2 2026, $383000.0 in Q1 2026, and $519000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Grace Therapeutics | 39.38 Mn | 39.38 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 557,000.00 |
| Mar 31, 2026 | 383,000.00 |
| Dec 31, 2025 | 519,000.00 |
| Sep 30, 2025 | 416,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 453,000.00 |
| Dec 31, 2024 | 583,000.00 |
| Sep 30, 2024 | 477,000.00 |
| Jun 30, 2024 | 622,000.00 |
| Mar 31, 2024 | 283,000.00 |
| Dec 31, 2023 | 811,000.00 |
| Sep 30, 2023 | 1.04 Mn |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 598,000.00 |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 1.54 Mn |
| Mar 31, 2022 | 720,000.00 |
| Dec 31, 2021 | 1.85 Mn |
| Sep 30, 2021 | 2.18 Mn |